Use of complementary and alternative therapies in epilepsy: Cause for concern

Archives of Neurology

Volumn 62, Issue 9, 2005, Pages 1472-1475

  Pearl, Phillip L ^a   Robbins, Emily L ^a   Bennett, Heather D ^a   Conry, Joan A ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABINOID; CANNABIS; CARBAMAZEPINE; CYTOCHROME P450; ETIRACETAM; GABAPENTIN; HERBACEOUS AGENT; KAVA; MELATONIN; PLACEBO; TETRAHYDROCANNABINOL; VALPROIC ACID;

ACUPUNCTURE; ALTERNATIVE MEDICINE; ANAPHYLAXIS; ANTICONVULSANT ACTIVITY; AUTONOMIC DYSFUNCTION; BETONY; BLUE COHOSH; BRADYCARDIA; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COMA; CONFUSION; CONTACT DERMATITIS; CROSS ALLERGY; DRUG ABSORPTION; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG MECHANISM; DRUG METABOLISM; DRUG TRANSPORT; ECHINACEA; EPILEPSY; FASCICULATION; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TOXICITY; HAZELNUT; HEART ARREST; HEART ARRHYTHMIA; HEPATITIS; HERB DRUG INTERACTION; HONEY; HUMAN; HYPERGLYCEMIA; HYPERICUM PERFORATUM; HYPERTENSION; HYPOTENSION; INTESTINE ABSORPTION; LIVER TOXICITY; LUNG TOXICITY; MAGNET; MANIPULATIVE MEDICINE; MEDICINAL PLANT; META ANALYSIS; MUGWORT; NEUROTOXICITY; NONHUMAN; PATIENT SATISFACTION; PIPSISSEWA; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RELIGION; RISK BENEFIT ANALYSIS; SEIZURE; SHORT SURVEY; SIDE EFFECT; SILYBUM MARIANUM; SKULLCAP; STRESS; STUPOR; TOBACCO; TRADITIONAL MEDICINE; TREATMENT OUTCOME; UTERUS CONTRACTION; VASOCONSTRICTION; VERATRUM; VISCUM ALBUM; YOGA;

ATTITUDE TO HEALTH; COMPLEMENTARY THERAPIES; EPILEPSY; HUMANS; RISK;

EID: 25144512887     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.62.9.1472     Document Type: Short Survey

References (31)

1. Gillis J. Herbal remedies turn deadly for patients; suits fail to bring tougher rules. Washington Post. September 5, 2004: A1.
2. Complementary treatment. Epilepsy Foundation Web site. Available at: http://www.epilepsyfoundation.org/answerplace/Medical/treatment/alternative/ index.cfm. Accessed on July 18, 2005.
3. Sirven JI, Drazkowski JF, Zimmerman RS, Bortz JJ, Shulman DL, Macleish M. Complementary/alternative medicine for epilepsy in Arizona. Neurology. 2003;61:576-577.
4. Gross-Tsur V, Lahad A, Shalev RS. Use of complementary medicine in children with attention deficient hyperactivity disorder and epilepsy. Pediatr Neurol. 2003;29:53-55.
5. Skidmore-Roth L. Mosby's Handbook of Herbs and Natural Supplements. St Louis, Mo: Mosby; 2001.
6. Fetrow CW, Avila JR, eds. Professional's Handbook of Complementary and Alternative Medicines, 2nd Edition. Springhouse, Pa: Springhouse Corp; 2001.
7. Blumenthal M, Goldberg A, Brinckmann J, eds. Herbal Medicine: Expanded Commission E Monographs. Newton, NJ: Integrative Medicine Communications; 2000.
8. Schapel GJ, Beran RG, Kennaway DL, McLoughney J, Matthews CD. Melatonin response in active epilepsy. Epilepsia. 1995;36:75-78.
9. Gordon E, Devinsky O. Alcohol and marijuana: effects of epilepsy and use by patients with epilepsy. Epilepsia. 2001;42:1266-1272.
10. Grunze H, Langosch J, Schirrmacher K, Bingmann D, Von Wegerer J, Walden J. Kava pyrones exert effects on neuronal transmission and transmembranous cation currents similar to established mood stabilizers: a review. Prog Neuropsychopharmacol Biol Psychiatry. 2001;25:1555-1570.
11. Pittler MH, Ernst E. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J Clin Psychopharmacol. 2000;20:84-89.
12. Volz HP, Kieser M. Kava-kava extract WS-1490 versus placebo in anxiety disorders: a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry. 1997;30:1-5.
13. Amabeoku GJ, Leng MJ, Syce JA. Antimicrobial and anticonvulsant activities of Viscum capense. J Ethnopharmacol. 1998;61:237-241.
14. Fairiello RG, Bubenik GA, Brown GM, Grota LJ. Epileptogenic action of intraventricularly injected antimelatonin antibody. Neurology. 1977;27:567-570.
15. Philo R, Reiter RJ. Characterization of pinealectomy induced convulsion in the Mongolian gerbil (Meriones unguiculatus). Epilepsia. 1978;19:485-492.
16. de Azevedo BA, Fontana P Jr. Audiogenic seizures and the pineal gland. Biol Psychiatry. 1988;23:734-740.
17. Miyamoto A, Hara M, Ito M, Hayashi K, Fukuyama Y. Serum melatonin kinetics in epileptic children with or without photosensitivity. Jpn J Psychiatry Neurol. 1990;44:432-433.
18. Sheldon SH. Pro-convulsant effects of oral melatonin in neurologically disabled children. Lancet. 1998;351:1254.
19. Fauteck J, Schmidt H, Lerchl A, Kurlemann G, Wittkowski W. Melatonin in epilepsy: first results of replacement therapy and clinical results. Biol Signals Recept. 1999;8:105-110.
20. Ashton CH. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101-106.
21. Wallace MJ, Blair RE, Falenski KW, Martin BR, De-Lorenzo RJ. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther. 2003;307:129-137.
22. Cunha JM, Carlini EA, Pereira AE, et al. Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology. 1980;21:175-185.
23. Grinspoon L, Bakalr JB. Marijuana, the Forbidden Medicine. New Haven, Conn: Yale University Press; 1993.
24. Robson P. Therapeutic aspects of cannabis and cannabinoids. Br J Psychiatry. 2001;178:107-115.
25. Connor KM, Davidson JRT, Churchill LE. Adverse-effect profile of kava. CNS Spectr. 2001;6:848-853.
26. Arendt J. Safety of melatonin in long-term use. J Biol Rhythms. 1997;12:673-681.
27. Meredith S, Jackson K, Dudenhoeffer G, Graham L, Epple J. Long-term supplementation with melatonin delays reproductive senescence in rats, without an effect on number of primordial follicles. Exp Gerontol. 2000;35:343-352.
28. Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther. 2000;294:88-95.
29. Li Y, Wang E, Patten CJ, Chen L, Yang CS. Effect of flavonoids on cytochrome P450-dependent acetaminophen metabolism in rats and human liver microsomes. Drug Metab Dispos. 1994;22:566-571.
30. Monteleone P, Tortorella A, Borriello R, Natale M, Cassandro P, Maj M. Suppression of nocturnal plasma melatonin levels by evening administration of sodium valproate in healthy humans. Biol Psychiatry. 1997;41:336-341.
31. Almeida JC, Grimsley EW. Coma from the health food store: interaction between kava and alprazolam. Ann Intern Med. 1996;125:940-941.